Evaluating the role of Toll-like receptors in diseases of the central nervous system

Takeuchi, 2010, Pattern recognition receptors and inflammation, Cell, 140, 805, 10.1016/j.cell.2010.01.022 Unterholzner, 2010, IFI16 is an innate immune sensor for intracellular DNA, Nat Immunol, 11, 997, 10.1038/ni.1932 O’Neill, 2008, The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress, Immunol Rev, 226, 10, 10.1111/j.1600-065X.2008.00701.x Kawai, 2010, The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors, Nat Immunol, 11, 373, 10.1038/ni.1863 O’Neill, 2007, The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling, Nat Rev Immunol, 7, 353, 10.1038/nri2079 Carty, 2006, The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling, Nat Immunol, 7, 1074, 10.1038/ni1382 Keating, 2007, IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination, J Biol Chem, 282, 33435, 10.1074/jbc.M705266200 Banerjee, 2006, Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells, Proc Natl Acad Sci U S A, 103, 3274, 10.1073/pnas.0511113103 Ostuni, 2010, Deciphering the complexity of Toll-like receptor signaling, Cell Mol Life Sci, 67, 4109, 10.1007/s00018-010-0464-x Farina, 2005, Preferential expression and function of Toll-like receptor 3 in human astrocytes, J Neuroimmunol, 159, 12, 10.1016/j.jneuroim.2004.09.009 Bowman, 2003, Cultured astrocytes express toll-like receptors for bacterial products, Glia, 43, 281, 10.1002/glia.10256 Tang, 2007, Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits, Proc Natl Acad Sci U S A, 104, 13798, 10.1073/pnas.0702553104 Mishra, 2006, Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis, J Neuroimmunol, 181, 46, 10.1016/j.jneuroim.2006.07.019 Lafon, 2006, The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA, J Mol Neurosci, 29, 185, 10.1385/JMN:29:3:185 Olson, 2004, Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs, J Immunol, 173, 3916, 10.4049/jimmunol.173.6.3916 Jack, 2005, TLR signaling tailors innate immune responses in human microglia and astrocytes, J Immunol, 175, 4320, 10.4049/jimmunol.175.7.4320 Carpentier, 2008, Glial toll-like receptor signaling in central nervous system infection and autoimmunity, Brain Behav Immun, 22, 140, 10.1016/j.bbi.2007.08.011 Hanisch, 2008, Toll-like receptors: roles in neuroprotection?, Trends Neurosci, 31, 176, 10.1016/j.tins.2008.01.005 Lehnardt, 2010, Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury, Glia, 58, 253 Akiyama, 2000, Inflammation and Alzheimer's disease, Neurobiol Aging, 21, 383, 10.1016/S0197-4580(00)00124-X Whitney, 2009, Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders, J Neurochem, 108, 1343, 10.1111/j.1471-4159.2009.05886.x Lehnardt, 2008, A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS, J Neurosci, 28, 2320, 10.1523/JNEUROSCI.4760-07.2008 Yang, 2010, The role of microglia in central nervous system immunity and glioma immunology, J Clin Neurosci, 17, 6, 10.1016/j.jocn.2009.05.006 Price, 1998, Mutant genes in familial Alzheimer's disease and transgenic models, Annu Rev Neurosci, 21, 479, 10.1146/annurev.neuro.21.1.479 Sudoh, 1998, Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid beta-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites, J Neurochem, 71, 1535, 10.1046/j.1471-4159.1998.71041535.x Iribarren, 2005, Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease, Immunol Res, 31, 165, 10.1385/IR:31:3:165 Walker, 2006, Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes, J Leukoc Biol, 79, 596, 10.1189/jlb.0705377 Murphy, 1998, Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells, J Biol Chem, 273, 20967, 10.1074/jbc.273.33.20967 Szczepanik, 2001, IL-4, IL-10 and IL-13 modulate A beta(1--42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line, J Neuroimmunol, 113, 49, 10.1016/S0165-5728(00)00404-5 Lue, 2001, Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro, Glia, 35, 72, 10.1002/glia.1072 Yates, 2000, Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia, J Neurochem, 74, 1017, 10.1046/j.1471-4159.2000.0741017.x Jana, 2008, Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease, J Immunol, 181, 7254, 10.4049/jimmunol.181.10.7254 Fassbender, 2004, The LPS receptor (CD14) links innate immunity with Alzheimer's disease, FASEB J, 18, 203, 10.1096/fj.03-0364fje Liu, 2005, LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide, Brain, 128, 1778, 10.1093/brain/awh531 Walter, 2007, Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease, Cell Physiol Biochem, 20, 947, 10.1159/000110455 Letiembre, 2009, Screening of innate immune receptors in neurodegenerative diseases: a similar pattern, Neurobiol Aging, 30, 759, 10.1016/j.neurobiolaging.2007.08.018 Minoretti, 2006, Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease, Neurosci Lett, 391, 147, 10.1016/j.neulet.2005.08.047 Frank, 2009, Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice, Neurosci Lett, 453, 41, 10.1016/j.neulet.2009.01.075 Reed-Geaghan, 2009, CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation, J Neurosci, 29, 11982, 10.1523/JNEUROSCI.3158-09.2009 Bamberger, 2003, A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation, J Neurosci, 23, 2665, 10.1523/JNEUROSCI.23-07-02665.2003 Cameron, 2010, Inflammation, microglia, and Alzheimer's disease, Neurobiol Dis, 37, 503, 10.1016/j.nbd.2009.10.006 Cui, 2002, Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells, J Immunol, 168, 434, 10.4049/jimmunol.168.1.434 Chen, 2006, Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide, J Biol Chem, 281, 3651, 10.1074/jbc.M508125200 Tang, 2008, Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal, Exp Neurol, 213, 114, 10.1016/j.expneurol.2008.05.014 Koenigsknecht-Talboo, 2005, Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines, J Neurosci, 25, 8240, 10.1523/JNEUROSCI.1808-05.2005 Trudler, 2010, Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application, Mediators Inflamm, 10.1155/2010/497987 Doi, 2009, Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease, Am J Pathol, 175, 2121, 10.2353/ajpath.2009.090418 Fischer, 2008, Toll-like receptors in autoimmunity, Ann N Y Acad Sci, 1143, 21, 10.1196/annals.1443.012 Prinz, 2006, Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis, J Clin Invest, 116, 456, 10.1172/JCI26078 Zamvil, 1990, The T lymphocyte in experimental allergic encephalomyelitis, Annu Rev Immunol, 8, 579, 10.1146/annurev.iy.08.040190.003051 O’Connor, 2008, Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis, J Immunol, 181, 3750, 10.4049/jimmunol.181.6.3750 Steinman, 2008, A rush to judgment on Th17, J Exp Med, 205, 1517, 10.1084/jem.20072066 Waldner, 2009, The role of innate immune responses in autoimmune disease development, Autoimmun Rev, 8, 400, 10.1016/j.autrev.2008.12.019 Marta, 2008, Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis, Eur J Immunol, 38, 565, 10.1002/eji.200737187 Touil, 2006, Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta, J Immunol, 177, 7505, 10.4049/jimmunol.177.11.7505 Fernandez, 2010, Orchestrating innate immune responses in multiple sclerosis: molecular players, J Neuroimmunol, 225, 5, 10.1016/j.jneuroim.2010.05.014 Lampropoulou, 2008, TLR-activated B cells suppress T cell-mediated autoimmunity, J Immunol, 180, 4763, 10.4049/jimmunol.180.7.4763 Bsibsi, 2002, Broad expression of Toll-like receptors in the human central nervous system, J Neuropathol Exp Neurol, 61, 1013, 10.1093/jnen/61.11.1013 Downes, 2010, Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?, Br J Pharmacol, 160, 1872, 10.1111/j.1476-5381.2010.00864.x Hartl, 1996, Experimental antileukocyte interventions in cerebral ischemia, J Cereb Blood Flow Metab, 16, 1108, 10.1097/00004647-199611000-00004 Qiu, 2010, High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia, Stroke, 41, 2077, 10.1161/STROKEAHA.110.590463 Hyakkoku, 2010, Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia, Neuroscience, 171, 258, 10.1016/j.neuroscience.2010.08.054 Hua, 2009, The TRIF-dependent signaling pathway is not required for acute cerebral ischemia/reperfusion injury in mice, Biochem Biophys Res Commun, 390, 678, 10.1016/j.bbrc.2009.10.027 Ziegler, 2007, TLR2 has a detrimental role in mouse transient focal cerebral ischemia, Biochem Biophys Res Commun, 359, 574, 10.1016/j.bbrc.2007.05.157 Abe, 2010, Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia, Stroke, 41, 898, 10.1161/STROKEAHA.109.572552 Marsh, 2009, Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3, J Neurosci, 29, 9839, 10.1523/JNEUROSCI.2496-09.2009 Stevens, 2008, Toll-like receptor 9: a new target of ischemic preconditioning in the brain, J Cereb Blood Flow Metab, 28, 1040, 10.1038/sj.jcbfm.9600606 Pradillo, 2009, Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning, J Neurochem, 109, 287, 10.1111/j.1471-4159.2009.05972.x Behin, 2003, Primary brain tumours in adults, Lancet, 361, 323, 10.1016/S0140-6736(03)12328-8 Hussain, 2006, Innate immune functions of microglia isolated from human glioma patients, J Transl Med, 4, 15, 10.1186/1479-5876-4-15 Grauer, 2008, TLR ligands in the local treatment of established intracerebral murine gliomas, J Immunol, 181, 6720, 10.4049/jimmunol.181.10.6720 Meng, 2008, Expression of TLR9 within human glioblastoma, J Neurooncol, 88, 19, 10.1007/s11060-008-9536-2 Alizadeh, 2010, Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy, Clin Cancer Res, 16, 3399, 10.1158/1078-0432.CCR-09-3087 Grauer, 2007, CD4+ FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo, Int J Cancer, 121, 95, 10.1002/ijc.22607 Carpentier, 2006, Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma, Neuro Oncol, 8, 60, 10.1215/S1522851705000475 Carpentier, 2010, Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study, Neuro Oncol, 12, 401, 10.1093/neuonc/nop047 Huang, 2008, TLR signaling by tumor and immune cells: a double-edged sword, Oncogene, 27, 218, 10.1038/sj.onc.1210904 Watkins, 2001, Glial activation: a driving force for pathological pain, Trends Neurosci, 24, 450, 10.1016/S0166-2236(00)01854-3 Kim, 2007, A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity, J Biol Chem, 282, 14975, 10.1074/jbc.M607277200 Watkins, 2003, Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain, Adv Exp Med Biol, 521, 1 Shi, 2010, The role of TLR2 in nerve injury-induced neuropathic pain is essentially mediated through macrophages in peripheral inflammatory response, Glia, 59, 231, 10.1002/glia.21093 Milligan, 2009, Pathological and protective roles of glia in chronic pain, Nat Rev Neurosci, 10, 23, 10.1038/nrn2533 Obata, 2008, Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury, J Neurochem, 105, 2249, 10.1111/j.1471-4159.2008.05353.x DeLeo, 2001, The role of neuroinflammation and neuroimmune activation in persistent pain, Pain, 90, 1, 10.1016/S0304-3959(00)00490-5 Wieseler-Frank, 2005, Central proinflammatory cytokines and pain enhancement, Neurosignals, 14, 166, 10.1159/000087655 Cao, 2009, The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain, Neuroscience, 158, 896, 10.1016/j.neuroscience.2008.10.004 Tanga, 2005, The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy, Proc Natl Acad Sci U S A, 102, 5856, 10.1073/pnas.0501634102 Watkins, 2009, The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia, Trends Pharmacol Sci, 30, 581, 10.1016/j.tips.2009.08.002 Togbe, 2007, Murine cerebral malaria development is independent of toll-like receptor signaling, Am J Pathol, 170, 1640, 10.2353/ajpath.2007.060889 Lepenies, 2008, Induction of experimental cerebral malaria is independent of TLR2/4/9, Med Microbiol Immunol, 197, 39, 10.1007/s00430-007-0057-y Coban, 2007, Pathological role of Toll-like receptor signaling in cerebral malaria, Int Immunol, 19, 67, 10.1093/intimm/dxl123 Sam-Agudu, 2010, TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria, Am J Trop Med Hyg, 82, 548, 10.4269/ajtmh.2010.09-0467 Aravalli, 2005, Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus, J Immunol, 175, 4189, 10.4049/jimmunol.175.7.4189 Kurt-Jones, 2004, Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis, Proc Natl Acad Sci U S A, 101, 1315, 10.1073/pnas.0308057100 Aravalli, 2007, Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia, J Neuroinflammation, 4, 11, 10.1186/1742-2094-4-11 Schachtele, 2010, Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2, J Neuroinflammation, 7, 35, 10.1186/1742-2094-7-35 Sorensen, 2008, TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain, J Immunol, 181, 8604, 10.4049/jimmunol.181.12.8604 Zhang, 2007, TLR3 deficiency in patients with herpes simplex encephalitis, Science, 317, 1522, 10.1126/science.1139522 Perez de Diego, 2010, Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis, Immunity, 33, 400, 10.1016/j.immuni.2010.08.014 Casrouge, 2006, Herpes simplex virus encephalitis in human UNC-93B deficiency, Science, 314, 308, 10.1126/science.1128346 Lehnardt, 2007, TLR2 and caspase-8 are essential for group B Streptococcus-induced apoptosis in microglia, J Immunol, 179, 6134, 10.4049/jimmunol.179.9.6134 Puliti, 2009, Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease, Infect Immun, 77, 1524, 10.1128/IAI.00965-08 Echchannaoui, 2002, Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation, J Infect Dis, 186, 798, 10.1086/342845 Koedel, 2003, Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis, J Immunol, 170, 438, 10.4049/jimmunol.170.1.438 Liu, 2009, Microglial activation by Citrobacter koseri is mediated by TLR4- and MyD88-dependent pathways, J Immunol, 183, 5537, 10.4049/jimmunol.0900083 Hawn, 2006, A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis, J Infect Dis, 194, 1127, 10.1086/507907 Thuong, 2007, A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis, Genes Immun, 8, 422, 10.1038/sj.gene.6364405 Rolls, 2007, Toll-like receptors modulate adult hippocampal neurogenesis, Nat Cell Biol, 9, 1081, 10.1038/ncb1629 Saper, 2009, A guide to the perplexed on the specificity of antibodies, J Histochem Cytochem, 57, 1, 10.1369/jhc.2008.952770 Bsibsi, 2006, Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators, Glia, 53, 688, 10.1002/glia.20328 Carpentier, 2005, Differential activation of astrocytes by innate and adaptive immune stimuli, Glia, 49, 360, 10.1002/glia.20117 Prehaud, 2005, Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon, J Virol, 79, 12893, 10.1128/JVI.79.20.12893-12904.2005 Marta, 2009, Regulation of autoimmune encephalomyelitis by toll-like receptors, Autoimmun Rev, 8, 506, 10.1016/j.autrev.2009.01.006 Lin, 2005, Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan, Atherosclerosis, 180, 305, 10.1016/j.atherosclerosis.2004.12.022